Cited In for PMID: 21603905

Year	Number of Results
2011	1
2012	4
2013	7
2014	3
2015	3
2016	1
2017	1
2018	1
2020	2
2021	1
2022	1
2024	0

1

Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.

Stearns-Kurosawa DJ, Collins V, Freeman S, Debord D, Nishikawa K, Oh SY, Leibowitz CS, Kurosawa S. Stearns-Kurosawa DJ, et al. Pediatr Nephrol. 2011 Nov;26(11):2031-9. doi: 10.1007/s00467-011-1913-y. Epub 2011 May 21. Pediatr Nephrol. 2011. PMID: 21603905 Free PMC article.

2

AB₅ Enterotoxin-Mediated Pathogenesis: Perspectives Gleaned from Shiga Toxins.

Biernbaum EN, Kudva IT. Biernbaum EN, et al. Toxins (Basel). 2022 Jan 16;14(1):62. doi: 10.3390/toxins14010062. Toxins (Basel). 2022. PMID: 35051039 Free PMC article. Review.

3

Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing Escherichia coli.

Hwang SB, Chelliah R, Kang JE, Rubab M, Banan-MwineDaliri E, Elahi F, Oh DH. Hwang SB, et al. Front Cell Infect Microbiol. 2021 Jun 29;11:614963. doi: 10.3389/fcimb.2021.614963. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34268129 Free PMC article. Review.

4

Large animal models for translational research in acute kidney injury.

Packialakshmi B, Stewart IJ, Burmeister DM, Chung KK, Zhou X. Packialakshmi B, et al. Ren Fail. 2020 Nov;42(1):1042-1058. doi: 10.1080/0886022X.2020.1830108. Ren Fail. 2020. PMID: 33043785 Free PMC article. Review.

5

Treatment Strategies for Infections With Shiga Toxin-Producing Escherichia coli.

Mühlen S, Dersch P. Mühlen S, et al. Front Cell Infect Microbiol. 2020 May 6;10:169. doi: 10.3389/fcimb.2020.00169. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32435624 Free PMC article. Review.

6

Exosome-associated Shiga toxin 2 is released from cells and causes severe toxicity in mice.

Watanabe-Takahashi M, Yamasaki S, Murata M, Kano F, Motoyama J, Yamate J, Omi J, Sato W, Ukai H, Shimasaki K, Ikegawa M, Tamura-Nakano M, Yanoshita R, Nishino Y, Miyazawa A, Natori Y, Toyama-Sorimachi N, Nishikawa K. Watanabe-Takahashi M, et al. Sci Rep. 2018 Jul 17;8(1):10776. doi: 10.1038/s41598-018-29128-9. Sci Rep. 2018. PMID: 30018364 Free PMC article.

7

Shiga Toxin Therapeutics: Beyond Neutralization.

Hall G, Kurosawa S, Stearns-Kurosawa DJ. Hall G, et al. Toxins (Basel). 2017 Sep 19;9(9):291. doi: 10.3390/toxins9090291. Toxins (Basel). 2017. PMID: 28925976 Free PMC article. Review.

8

Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition.

Mitsui T, Watanabe-Takahashi M, Shimizu E, Zhang B, Funamoto S, Yamasaki S, Nishikawa K. Mitsui T, et al. Infect Immun. 2016 Aug 19;84(9):2653-61. doi: 10.1128/IAI.00149-16. Print 2016 Sep. Infect Immun. 2016. PMID: 27382021 Free PMC article.

9

Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype.

Rahal EA, Fadlallah SM, Nassar FJ, Kazzi N, Matar GM. Rahal EA, et al. Front Cell Infect Microbiol. 2015 Mar 18;5:24. doi: 10.3389/fcimb.2015.00024. eCollection 2015. Front Cell Infect Microbiol. 2015. PMID: 25853096 Free PMC article. Review.

10

Complement, thrombotic microangiopathy and disseminated intravascular coagulation.

Kurosawa S, Stearns-Kurosawa DJ. Kurosawa S, et al. J Intensive Care. 2014 Dec 31;2(1):65. doi: 10.1186/s40560-014-0061-4. eCollection 2014. J Intensive Care. 2014. PMID: 25705421 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

23 results

Results by year